Rapport Therapeutics, Inc. · NASDAQ:RAPP
Paul Steven M bought 35,714 Rapport Therapeutics, Inc. shares (Form 4)
Traded Oct 22, 2026 · Filed Oct 22, 2026
On Oct 22, 2026, Paul Steven M (Director) bought 35,714 Rapport Therapeutics, Inc. shares at US$27.28 for US$974K, leaving 77,380 shares. Filed Oct 22, 2026 (Form 4).
- Bought
- 35,714 shares
- Price
- US$27.28
- Value
- US$974K
- Holding after
- 77,380 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Common Stock | Buy | 35,714 | US$27.28 | 77,380 | Indirect |
Source
Download original · View original at SEC